Clinical Trials on Keratosis Pilaris

Total 1713 results

Peplin

Completed

A Long Term Follow up Study of Patients Who Have Complete Clearance of Their Actinic Keratosis (AK) Lesions at the Day 57 Visit in the PEP005-028 Study

Actinic Keratosis

United States
Peplin

Completed

Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Actinic Keratoses

Actinic Keratosis

Australia
Taro Pharmaceuticals USA

Completed

Bioequivalence Study of Two Imiquimod Cream 5%

Actinic Keratosis

United States
Taro Pharmaceuticals USA

Completed

Clinical Study to Evaluate the Bioequivalence of Two Imiquimod Cream 3.75% Formulations in Patients With Actinic Keratosis.

Actinic Keratosis
Medicis Global Service Corporation

Unknown

Potential Effect of Topical Imiquimod on Atrial Ectopy in Patients With Actinic Keratosis

Actinic Keratosis

United States
Graceway Pharmaceuticals, LLC

Completed

Safety and Effectiveness Study of Actinic Keratosis Treatment Following Cryosurgery

Actinic Keratosis

United States, Canada
Actavis Inc.

Completed

An Equivalence Study of Generic Ingenol Mebutate Gel 0.015% and Picato Gel 0.015% in Subjects With Actinic Keratosis

ACTINIC KERATOSIS

United States
Aclaris Therapeutics, Inc.

Completed

An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses (SK-FAN)

Seborrheic Keratosis

United States
Bispebjerg Hospital
Galderma R&D

Completed

Laser and Microdermabrasion Before Photodynamic Therapy for Actinic Keratoses in Field-cancerized Skin

Actinic Keratosis | Sun Damaged Skin | Solar Keratosis | Solar Skin Damage
The Cleveland Clinic

Completed

Biomarker Database Registry for Photodynamic Therapy

Actinic Keratosis

United States
MEDA Pharma GmbH & Co. KG

Completed

A Study to Evaluate the Effectiveness and Safety of Multiple Applications of Imiquimod 5% Cream for the Treatment of Actinic Keratoses in Organ Transplant Recipients

Actinic Keratosis
Northwestern University

Withdrawn

Ingenol Mebutate Compared to Cryotherapy for the Treatment of Skin Lesions

Actinic Keratosis
Padagis LLC

Completed

To Compare Safety and Efficacy of Perrigo's Drug Product Compared to an FDA Approved Drug Product in the Treatment of Actinic Keratosis

Actinic Keratosis
Galderma R&D

Completed

Gene Expression in Renal Transplant Patients With Field Actinic Keratosis Undergoing Metvix® Photodynamic Therapy (PDT)

Actinic Keratosis

United Kingdom
Icahn School of Medicine at Mount Sinai
Bausch Health Americas, Inc.

Completed

Perimenstrual Acne With Clindamycin Phosphate and Benzoyl Peroxide

Actinic Keratosis

United States
Actavis Inc.

Completed

A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® (Diclofenac Sodium) Gel 3% in the Treatment of Actinic Keratosis

Actinic Keratosis

United States
Gage Development Company, LLC

Completed

Study Comparing GDC 695 and Diclofenac Sodium Gel, 3% in Subjects With Actinic Keratoses

Actinic Keratosis

United States
Actavis Inc.

Completed

A Study to Evaluate the Safety and Efficacy Imiquimod Cream, 2.5% in Participants With Actinic Keratoses

Actinic Keratosis

United States
LEO Pharma

Completed

The Real Life Topical Field Treatment of Actinic Keratosis Study (RAPID-ACT)

Actinic Keratosis

Netherlands
Actavis Inc.

Completed

Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis

Actinic Keratosis

United States
LEO Pharma

Completed

The Use of Picato® (Ingenol Mebutate) to Treat Actinic Keratosis in Standard Clinical Practice (PrAKtice)

Actinic Keratosis

Greece
Wake Forest University

Completed

Measuring Adherence To Topical 5-Fluorouracil in a Clinic Population

Actinic Keratosis

United States
University of Chicago

Withdrawn

Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses

Actinic Keratosis

United States
Athenex, Inc.

Completed

Ph 1, Single-Center, Safety, Tolerability & Pharmacokinetic Study of KX2 391 Ointment in Subj. w Actinic Keratosis

Actinic Keratosis

United States
photonamic GmbH & Co. KG

Completed

Photodynamic Therapy of Actinic Keratoses With Alacare®

Actinic Keratosis

Germany
DUSA Pharmaceuticals, Inc.

Completed

Twelve Month Follow-Up of CP0108

Actinic Keratosis

United States
Biofrontera Bioscience GmbH

Completed

A Clinical Trial of Topical Photodynamic Therapy With 5-aminolevulinic Acid for the Treatment of Actinic Keratosis

Actinic Keratosis
Promius Pharma, LLC

Completed

ACT01 in Combination With Comp01-04 in Patients With Actinic Keratosis

Actinic Keratosis

United States
Dong-A University

Completed

Efficacy of Iontophoresis-assisted AFL-PDT in Actinic Keratosis

Actinic Keratosis
Peplin

Completed

Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses

Actinic Keratosis

United States
Peplin
Omnicare Clinical Research

Completed

A Study to Examine the Safety and Toleration of PEP005 Topical Gel in Patients With Actinic Keratoses on the Top of the Hand

Actinic Keratosis

United States
Peplin

Completed

A Long Term Follow up Study of Patients Who Have Completed the PEP005-020 Study

Actinic Keratosis

United States, Australia
Peplin

Completed

A Study to Evaluate the Pharmacokinetics of PEP005 (Ingenol Mebutate) Gel, 0.05%, When Applied in a Maximal Use Setting to the Dorsal Aspect of the Forearm in Patients With Actinic Keratosis

Actinic Keratosis

United States
Taro Pharmaceuticals USA

Completed

A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® Gel 3% in the Treatment of Actinic Keratosis

Actinic Keratosis
Lithuanian University of Health Sciences

Completed

Photodynamic Treatment of Actinic Keratoses With Different Light Doses

Actinic Keratosis

Lithuania
Innovaderm Research Inc.
Galderma Canada

Completed

Short Incubation Methylaminolevulinate Photodynamic Therapy Without Occlusion

Actinic Keratosis

Canada
Graceway Pharmaceuticals, LLC

Completed

Cellular and Molecular Events During Treatment of Actinic Keratosis With Imiquimod 5% Cream

Actinic Keratosis

United States
Apotex Inc.

Completed

A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Therapeutic Equivalence Study of Three Imiquimod Cream 5% Treatments for Patients With Actinic Keratosis

Actinic Keratosis
photonamic GmbH & Co. KG

Completed

PD P 506 A-PDT Versus Placebo-PDT and Cryosurgery for the Treatment of AK

Actinic Keratosis

Germany
LEO Pharma

Completed

Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp

Actinic Keratosis (AK)

Germany
Assuta Hospital Systems

Completed

Evaluation of a Topical Treatment for Actinic Keratosis

Actinic Keratosis of Face and Scalp

Israel
Wright State University

Completed

Photodynamic Therapy-Induced Immune Modulation: Part III

Actinic Keratosis | Photodynamic Therapy

United States
LEO Pharma

Completed

Efficacy and Safety of Ingenol Mebutate Gel 0.06% When Applied Once Daily for 2, 3 or 4 Consecutive Days to a Treatment Area of Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis

Actinic Keratosis

United States
National Cancer Institute (NCI)

Recruiting

Testing the Efficacy of Topical Calcipotriene Plus 5-Fluorouracil Combination to Activate the Immune System Against Precancerous Skin Lesions in Organ Transplant Recipients

Actinic Keratosis

United States
Infectopharm Arzneimittel GmbH
Gesellschaft für Therapieforschung mbH

Completed

5% KOH Solution vs. Placebo and Diclofenac Gel for the Treatment of Actinic Keratosis (KOHDIAK)

Actinic Keratosis

Germany
Biofrontera Bioscience GmbH

Completed

Safety and Efficacy Study for the Field-directed Treatment of Actinic Keratosis (AK) With Photodynamic Therapy (PDT)

Actinic Keratosis

Germany
Dartmouth-Hitchcock Medical Center
Norris Cotton Cancer Center

Completed

Indoor Daylight Photo Dynamic Therapy for Actinic Keratosis

Actinic Keratosis

United States
Northwestern University

Withdrawn

Electrocautery vs Q-switch for Seborrheic Keratosis

Keratosis, Seborrheic
Padagis LLC

Completed

To Compare Safety and Efficacy of Perrigo's Drug Compared to an FDA Approved Drug in the Treatment of Actinic Keratosis

Actinic Keratosis
Icahn School of Medicine at Mount Sinai
Bausch Health Americas, Inc.

Completed

Genomic Markers Before and After Treatment of Actinic Keratosis With Imiquimod 3.75% Cream

Actinic Keratosis

United States

3

Subscribe